Clinical data
| No | Gender | Age of recipient (years) | Age of donor (years) | Primary disease | Mismatch | Intention to treat | Maintenance of immunosuppressive regimen | Time from transplant to biopsy | Previous episode of acute graft rejection |
| 1 | F | 60 | 71 | Atherosclerosis renovascular disease | 6 | Anti-CD25, steroids, CyA, MMF | Steroids, CyA, MMF | 28 days (graft failure) | – |
| 2 | F | 55 | 66 | ADPKD | 3 | Anti-CD25, steroids, CyA, sirolimus | Steroids, CyA, sirolimus | 152 days (5 months) | – |
| 3 | F | 55 | 69 | ADPKD | 5 | Anti-CD25, steroids, tacrolimus, MMF | Steroids, tacrolimus, MMF | 20 months | – |
| 4 | M | 61 | 82 | ADPKD | 4 | Anti-CD25, tacrolimus, MMF | Tacrolimus, MMF | 15 days (graft failure) | – |
| 5 | M | 44 | 17 | ADPKD | 3 | Anti-CD25, steroids, CyA, sirolimus | Steroids, CyA, sirolimus | 52 days | – |
| 6 | M | 22 | 63 | Unknown | 4 | Anti-CD25, steroids, CyA, sirolimus | Steroids, CyA, sirolimus | 119 days (4 months) | – |
ADPKD, autosomal dominant polycystic kidney disease; CyA, ciclosporin A; MMF, mycophenolate mofetil.